4 -

4 - Romanowski B, Schwarz TF, Ferguson LM et al. Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared with the licensed 3-dose schedule: results from a randomized study. Human vaccines. 2011;7(12):1374-86 [link]